Distribution of left ventricular ejection fraction and heart rate values in a cohort of stable coronary patients: the INDYCE registry

Arch Cardiovasc Dis. 2010 Jun-Jul;103(6-7):354-62. doi: 10.1016/j.acvd.2010.05.002. Epub 2010 Jul 23.

Abstract

Background: The distribution of left ventricular ejection fraction (LVEF) - a key factor in coronary artery disease (CAD) patient management and prognostication - is poorly documented.

Objective: To determine LVEF and heart rate (HR) values, and describe the management of stable CAD patients in France.

Methods: The INDYCE survey was a prospective, multicentre registry of consecutive stable CAD outpatients attending a cardiology consultation. The survey focused on LVEF values measured using the echocardiographic Simpson biplane method. Drug therapy, resting HR, blood pressure and symptoms were also recorded.

Results: Overall, 3119 patients (68.4 +/- 11.0 years; 80% men) were enrolled. LVEF was 56.1+/-11.8% on average, and was poor (<40%) and moderately impaired (40-50%) in 9.6% (n=298) and 19.8% (n=619) of cases, respectively. Symptomatic angina pectoris was present in 19.2% of cases and only 40.6% of patients were asymptomatic (no angina and NYHA class < or = I) despite relatively aggressive management (79.0% of patients had undergone coronary angioplasty and/or bypass graft). Interestingly, 14.1% of patients with LVEF less than 40% were asymptomatic. In multivariable analysis, LVEF less than 40% was associated most strongly with symptomatic status (odds ratio 3.82; 95% CI 2.59-5.63; P<0.0001), together with female sex, age greater than 75 years, diabetes, HR greater or equal to 70 bpm, sedentariness, obesity and disease duration.

Conclusion: Only 9.6% of stable CAD patients had severe left ventricular dysfunction; among them, 14.1% were strictly asymptomatic. This could justify regular LVEF measurement in CAD patients. Three potentially reversible factors (HR>or=70 bpm, being overweight and sedentariness) were linked independently to the presence of symptoms.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Blood Pressure
  • Cardiovascular Agents / therapeutic use
  • Chi-Square Distribution
  • Coronary Artery Disease / diagnostic imaging
  • Coronary Artery Disease / drug therapy
  • Coronary Artery Disease / epidemiology
  • Coronary Artery Disease / physiopathology*
  • Cross-Sectional Studies
  • Female
  • France / epidemiology
  • Heart Rate*
  • Humans
  • Logistic Models
  • Male
  • Middle Aged
  • Outpatients
  • Prospective Studies
  • Registries
  • Stroke Volume*
  • Treatment Outcome
  • Ultrasonography
  • Ventricular Function, Left*

Substances

  • Cardiovascular Agents